• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

整块经尿道切除诊断的固有层垂直侵犯是 pT1 膀胱癌进展的一个重要预测指标。

Vertical Lamina Propria Invasion Diagnosed by En Bloc Transurethral Resection is a Significant Predictor of Progression for pT1 Bladder Cancer.

机构信息

Department of Urology, The Jikei University Kashiwa Hospital, Kashiwa, Chiba, Japan.

Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.

出版信息

J Urol. 2021 Jun;205(6):1622-1628. doi: 10.1097/JU.0000000000001630. Epub 2021 Jan 27.

DOI:10.1097/JU.0000000000001630
PMID:33502235
Abstract

PURPOSE

T1 bladder cancer is characterized by high recurrence and aggressive progression. Muscularis mucosae invasion may be a prognostic factor for progression, but the limitations of conventional transurethral resection of bladder tumors make diagnosis difficult. We correlated degree of invasion with oncologic outcome and evaluated the utility of pathological diagnosis following en bloc resection of bladder tumors.

MATERIALS AND METHODS

We retrospectively analyzed the records of 123 consecutive patients diagnosed with pT1 bladder cancer between November 2013 and December 2018. Transurethral resection was conducted in 91 patients, and en bloc resection in 32 patients. All specimens were analyzed for invasion depth and pT1 substaging (T1a/b: invasion above or into/beyond muscularis mucosae, pT1m/e: microinvasive or extensively invasive). Primary end points were prognostic values of pT1 substaging and invasion depth. The secondary end point was the pathological diagnostic utility of en bloc resection.

RESULTS

Median followup was 23 months. Three-year progression-free survival rate differed significantly depending on muscularis mucosae invasion (pT1a: 97.3%, pT1b: 72.8%; p=0.003) and invasion depth from basal membrane (<2 mm: 90.6%, ≥2 mm: 77.9%; p=0.03). Multivariate analysis showed that sessile tumor and invasion depth from basal membrane ≥2 mm were independent prognostic factors for progression. Diagnostic rates for pT1a/b and invasion depth were 77.6% and 85.9%, respectively, with transurethral resection, but 100% and 100% with en bloc resection (p=0.01 and p=0.03).

CONCLUSIONS

Vertical lamina propria invasion is predictive of progression in T1 bladder cancer, underlining the importance of accurately diagnosing the degree of vertical lamina propria invasion with en bloc resection.

摘要

目的

T1 膀胱癌的特点是高复发率和侵袭性进展。黏膜肌层浸润可能是进展的预后因素,但传统经尿道膀胱肿瘤切除术的局限性使得诊断困难。我们将浸润程度与肿瘤学结果相关联,并评估整块切除膀胱肿瘤后的病理诊断的效用。

材料和方法

我们回顾性分析了 2013 年 11 月至 2018 年 12 月连续 123 例诊断为 pT1 膀胱癌患者的记录。91 例行经尿道切除术,32 例行整块切除术。所有标本均分析浸润深度和 pT1 亚分期(T1a/b:黏膜肌层以上或进入/超越黏膜肌层,pT1m/e:微侵袭或广泛侵袭)。主要终点是 pT1 亚分期和浸润深度的预后价值。次要终点是整块切除的病理诊断效用。

结果

中位随访时间为 23 个月。根据黏膜肌层浸润(pT1a:97.3%,pT1b:72.8%;p=0.003)和基底膜浸润深度(<2mm:90.6%,≥2mm:77.9%;p=0.03),三年无进展生存率有显著差异。多变量分析显示,基底膜浸润深度≥2mm 和基底膜浸润深度≥2mm 是进展的独立预后因素。经尿道切除术的 pT1a/b 和浸润深度的诊断率分别为 77.6%和 85.9%,而整块切除术的诊断率分别为 100%和 100%(p=0.01 和 p=0.03)。

结论

垂直固有层浸润是 T1 膀胱癌进展的预测因素,强调了整块切除准确诊断垂直固有层浸润程度的重要性。

相似文献

1
Vertical Lamina Propria Invasion Diagnosed by En Bloc Transurethral Resection is a Significant Predictor of Progression for pT1 Bladder Cancer.整块经尿道切除诊断的固有层垂直侵犯是 pT1 膀胱癌进展的一个重要预测指标。
J Urol. 2021 Jun;205(6):1622-1628. doi: 10.1097/JU.0000000000001630. Epub 2021 Jan 27.
2
Prognosis of patients with T1 bladder cancer after en bloc transurethral resection of bladder tumor stratified by invasion to the level of the muscularis mucosa.根据肿瘤侵犯至黏膜肌层水平分层的T1期膀胱癌患者经尿道整块膀胱肿瘤切除术后的预后
Int Urol Nephrol. 2021 Jun;53(6):1105-1109. doi: 10.1007/s11255-020-02772-9. Epub 2021 Jan 2.
3
pT1 Subclassification Predicts Progression-Free Survival in En Bloc Resection of Bladder Tumor Specimens.整块切除膀胱肿瘤标本中 pT1 亚分类预测无进展生存期。
Arch Pathol Lab Med. 2024 May 1;148(5):573-580. doi: 10.5858/arpa.2023-0044-OA.
4
Prognostic value of micrometric substaging in pT1 bladder cancer patients treated with en-bloc transurethral resection.在整块经尿道切除治疗的 pT1 膀胱癌患者中,微分级亚分期的预后价值。
Histopathology. 2024 Jul;85(1):92-103. doi: 10.1111/his.15177. Epub 2024 Mar 13.
5
Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review.在非肌肉浸润性膀胱癌中鉴别黏膜肌层浸润(T1a 与 T1b)的预后意义:法国全国多中心研究及中心病理复查。
J Urol. 2013 Jun;189(6):2069-76. doi: 10.1016/j.juro.2012.11.120. Epub 2012 Nov 28.
6
Feasibility and accuracy of pathological diagnosis in en-bloc transurethral resection specimens versus conventional transurethral resection specimens of bladder tumour: evaluation with pT1 substaging by 10 pathologists.整块经尿道切除标本与传统经尿道切除标本在膀胱肿瘤病理诊断中的可行性和准确性:10 位病理学家评估 pT1 亚分期的效果。
Histopathology. 2021 Jun;78(7):943-950. doi: 10.1111/his.14307. Epub 2021 Mar 26.
7
Resection for Bladder Tumors: An Updated Systematic Review and Meta-Analysis of Its Differential Effect on Safety, Recurrence and Histopathology.膀胱肿瘤切除术:安全性、复发和组织病理学差异效果的更新系统评价和荟萃分析。
J Urol. 2022 Apr;207(4):754-768. doi: 10.1097/JU.0000000000002444. Epub 2022 Jan 21.
8
Substaging of pT1 Urothelial Bladder Carcinoma Predicts Tumor Progression and Overall Survival.pT1 尿路上皮膀胱癌的亚分期可预测肿瘤进展和总生存。
Urol Int. 2022;106(2):130-137. doi: 10.1159/000515650. Epub 2021 May 7.
9
Clinical significance of urothelial carcinoma ambiguous for muscularis propria invasion on initial transurethral resection of bladder tumor.初发经尿道膀胱肿瘤切除术时肌层浸润状态不明确的尿路上皮癌的临床意义。
World J Urol. 2020 Feb;38(2):389-395. doi: 10.1007/s00345-019-02782-y. Epub 2019 Apr 27.
10
Clinical Significance of Horizontal and Vertical Margin of En Bloc Resection for Nonmuscle Invasive Bladder Cancer.整块切除术水平和垂直切缘对非肌肉浸润性膀胱癌的临床意义。
J Urol. 2021 Aug;206(2):252-259. doi: 10.1097/JU.0000000000001735. Epub 2021 Mar 29.

引用本文的文献

1
Recent Advances and Emerging Innovations in Transurethral Resection of Bladder Tumor (TURBT) for Non-Muscle Invasive Bladder Cancer: A Comprehensive Review of Current Literature.非肌层浸润性膀胱癌经尿道膀胱肿瘤切除术(TURBT)的最新进展与新兴创新:当前文献综述
Res Rep Urol. 2025 Mar 14;17:69-85. doi: 10.2147/RRU.S386026. eCollection 2025.
2
An updated systematic review, meta-analysis, and trial sequential analysis of the efficacy and safety of en bloc transurethral resection vs. conventional transurethral resection for nonmuscle-invasive bladder tumor.整块经尿道切除术与传统经尿道切除术治疗非肌层浸润性膀胱肿瘤的疗效和安全性的最新系统评价、荟萃分析及试验序贯分析
Int J Surg. 2025 Apr 1;111(4):3061-3077. doi: 10.1097/JS9.0000000000002291.
3
Current opinions regarding the clinical utility of en bloc resection in the treatment of non-muscle invasive bladder cancer-a review of the literature.关于整块切除在非肌层浸润性膀胱癌治疗中的临床应用的当前观点——文献综述
Discov Oncol. 2024 Oct 19;15(1):574. doi: 10.1007/s12672-024-01452-9.
4
Thulium laser en bloc resection reduces recurrence rates in NMIBC patients with tumor diameters ≥3cm compared to transurethral resection: a non-randomized controlled study.钬激光整块切除术与经尿道切除术相比,可降低肿瘤直径≥3cm 的非肌层浸润性膀胱癌(NMIBC)患者的复发率:一项非随机对照研究。
BMC Cancer. 2024 Oct 8;24(1):1239. doi: 10.1186/s12885-024-13022-x.
5
Experts' recommendations in laser use for the treatment of bladder cancer: a comprehensive guide by the European Section of Uro-Technology (ESUT) and Training and Research in Urological Surgery and Technology (TRUST)-Group.专家关于膀胱癌激光治疗应用的建议:欧洲泌尿技术协会(ESUT)和泌尿外科手术与技术培训和研究(TRUST)组的综合指南。
World J Urol. 2024 Feb 14;42(1):79. doi: 10.1007/s00345-024-04786-9.
6
Transurethral Resection of Bladder Tumor: Novel Techniques in a New Era.经尿道膀胱肿瘤切除术:新时代的新技术。
Bladder (San Franc). 2023 Nov 9;10:e21200009. doi: 10.14440/bladder.2023.865. eCollection 2023.
7
En bloc resection of bladder tumour: the rebirth of past through reminiscence.整块切除膀胱肿瘤:怀旧再现过去。
World J Urol. 2023 Oct;41(10):2599-2606. doi: 10.1007/s00345-023-04547-0. Epub 2023 Aug 16.
8
ASO Author Reflections: Is T1HG Bladder Cancer a Good Candidate for En Bloc Resection?ASO作者反思:T1HG膀胱癌是否是整块切除的合适候选对象?
Ann Surg Oncol. 2023 Jun;30(6):3829-3830. doi: 10.1245/s10434-023-13291-z. Epub 2023 Mar 12.
9
En Bloc Resection Versus Conventional TURBT for T1HG Bladder Cancer: A Propensity Score-Matched Analysis.整块切除术与常规经尿道膀胱肿瘤切除术治疗 T1HG 膀胱癌:倾向评分匹配分析。
Ann Surg Oncol. 2023 Jun;30(6):3820-3828. doi: 10.1245/s10434-023-13227-7. Epub 2023 Mar 10.
10
Do we need repeat transurethral resection after en bloc resection for pathological T1 bladder cancer?整块切除术后是否需要对病理 T1 期膀胱癌进行重复经尿道切除术?
BJU Int. 2023 Feb;131(2):190-197. doi: 10.1111/bju.15760. Epub 2022 May 13.